Home › Asset managers › Compare 2023-2024 › Charles Schwab vs Jackson National
Charles Schwab 2023-2024 · Jackson National 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 4,578 | 3,845 | 255 | 478 | 93.8% | 90.4% |
| Board proposals | 3,667 | 3,217 | 196 | 254 | 94.3% | 91.7% |
| E&S shareholder proposals | 221 | 142 | 5 | 74 | 96.6% | 88.8% |
| Other items | 690 | 486 | 54 | 150 | 90.0% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
450 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | Jackson National |
|---|---|---|---|---|---|---|
| 908 DEVICES INC. | June 13, 2024 | To elect two Class I directors to hold office until the 2027 annual meeting of stockholders: Fenel M. Eloi Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| AADI BIOSCIENCE INC. | June 11, 2024 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| AARON'S COMPANY INC. | May 15, 2024 | Approval, on a non-binding, advisory basis, of the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| ACME UNITED CORP. | April 22, 2024 | Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the proxy statement. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ACUMEN PHARMACEUTICALS INC. | June 4, 2024 | To elect two Class III directors to the Board of Directors, each to hold office until the 2027 Annual Meeting of Stockholders: Daniel O'Connell Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| ADT INC. | May 22, 2024 | Approval of an amendment to the omnibus incentive plan to increase the number of shares of common stock authorized for issuance thereunder and extend the term Compensation |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| ALDEYRA THERAPEUTICS INC. | June 4, 2024 | To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| AMBAC FINANCIAL GROUP INC. | June 5, 2024 | To approve Ambac's 2024 Incentive Compensation Plan Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| AMERANT BANCORP INC. | May 8, 2024 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers - Say-on-Pay. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| AMERICAN NATIONAL BANKSHARES INC. | November 14, 2023 | Proposal to approve, on an advisory (non-binding) basis, specified compensation that may be paid or become payable to the named executive officers of American National that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ANAPTYSBIO INC. | June 12, 2024 | To approve the amendment and restatement of our 2017 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ANAPTYSBIO INC. | June 12, 2024 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| APOLLO COMMERCIAL REAL ESTATE FINANCE | June 7, 2024 | Approval, on an advisory basis, of the compensation of Apollo Commercial Real Estate Finance, Inc.'s named executive officers, as more fully described in the 2024 Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | June 14, 2024 | To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| ARIS WATER SOLUTIONS INC. | May 9, 2024 | Amend the Aris Water Solutions, Inc. 2021 Equity Incentive Plan to increase the number of shares of common stock that may be issued under the plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| ARKO CORP. | June 6, 2024 | Amend the ARKO Corp. 2020 Incentive Compensation Plan to increase the number of shares of the Company's common stock, par value $0.0001 per share, available for awards thereunder. Compensation |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| AUTOHOME INC. | June 21, 2024 | As an ordinary resolution: THAT Dr. Fan Lu be re-elected as a director of the Company and each director of the Company be and is hereby authorized to take any and every action that might be necessary to effect the foregoing resolution as such director, in his or her absolute discretion, thinks fit. Director Elections |
Board | Not determined | FOR 1 fund |
AGAINST 1 fund |
| AUTOHOME INC. | June 21, 2024 | As an ordinary resolution: THAT Mr. Tao Wu be re-elected as a director of the Company and each director of the Company be and is hereby authorized to take any and every action that might be necessary to effect the foregoing resolution as such director, in his or her absolute discretion, thinks fit. Director Elections |
Board | Not determined | FOR 1 fund |
AGAINST 1 fund |
| AUTOHOME INC. | June 21, 2024 | As an ordinary resolution: THAT Ms. Keke Ding be re-elected as a director of the Company and each director of the Company be and is hereby authorized to take any and every action that might be necessary to effect the foregoing resolution as such director, in his or her absolute discretion, thinks fit. Director Elections |
Board | Not determined | FOR 1 fund |
AGAINST 1 fund |
| AXT INC. | May 16, 2024 | To approve an amendment to the 2015 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 3,600,000. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| BANDWIDTH INC. | May 23, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement; and Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| BEAM THERAPEUTICS INC. | June 5, 2024 | Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| BEYOND INC. | May 21, 2024 | A non-binding advisory vote to approve the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| BGSF INC. | August 9, 2023 | Approval of Amendments to the BGSF, Inc. 2013 Long-Term Incentive Plan, including to add an additional 250,000 shares of common stock available for issuance. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BIG LOTS INC. | May 29, 2024 | APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. The Board of Directors recommends a vote FOR the approval of the compensation of Big Lots' named executive officers, as disclosed in the Proxy Statement pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion accompanying the tables. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| BIOATLA INC. | June 13, 2024 | Approve, by a non-binding advisory vote, the executive compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| BIOTE CORP. | May 21, 2024 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and Audit-related |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| BIRKENSTOCK HOLDING PLC | May 15, 2024 | To Re-Appoint Anne Pitcher As A Class I Director Of The Company. Director Elections |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| BLACKSTONE MORTGAGE TRUST INC. | June 21, 2024 | Advisory Vote on Executive Compensation: To approve in a non-binding, advisory vote, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| BROADWIND INC. | May 16, 2024 | To cast a non-binding advisory vote approving the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| C4 THERAPEUTICS INC. | June 20, 2024 | To cast a non-binding, advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CAPRI HOLDINGS LTD. | October 25, 2023 | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Capri Holdings Limited's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 6 funds |
| CARGURUS INC. | June 5, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2023. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| CARIBOU BIOSCIENCES INC. | June 13, 2024 | Election of three Class III directors to serve until the Company's 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The three nominees for election are: Rachel Haurwitz, Ph.D. Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| CARPARTS.COM INC. | May 23, 2024 | Approval of an advisory (non-binding) resolution regarding the compensation of our named executive officers, or the Say-on-Pay Proposal. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CENTURY CASINOS INC. | June 24, 2024 | To consider and vote upon a proposal to approve an advisory (non-binding) resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CHARGEPOINT HOLDINGS INC. | July 18, 2023 | The advisory approval of the compensation of our named executive officers ("Say-on-Pay"); and Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| CLAROS MORTGAGE TRUST INC. | June 4, 2024 | Advisory vote to approve the compensation of Claros Mortgage Trust, Inc.'s named executive officers, as more fully described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| CLEARWATER ANALYTICS HOLDINGS INC. | June 11, 2024 | Elect the three persons named in the proxy statement as Class III directors for terms of three years: Eric Lee Director Elections |
Board | For | FOR 3 funds |
WITHHOLD 1 fund |
| CNH INDUSTRIAL N V | May 3, 2024 | Re-appointment of Alessandro Nasi Other |
Board | For | FOR 10 funds |
AGAINST 5 funds |
| COMMUNITY HEALTHCARE TRUST INC. | May 2, 2024 | To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2024 annual meeting of stockholders. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| COMSCORE INC. | June 12, 2024 | The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company's common stock available for grant by 900,000 Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| CONAGRA BRANDS INC. | September 14, 2023 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| CORVUS PHARMACEUTICALS INC. | June 13, 2024 | To elect one Class II Director with term to expire at the 2027 annual meeting of stockholders: Scott W. Morrison Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| COSTAMARE INC. | October 3, 2023 | Election of Class I Director to hold office for a three-year term expiring at the 2026 annual meeting: Konstantinos Zacharatos Director Elections |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CRINETICS PHARMACEUTICALS INC. | June 7, 2024 | To elect two directors to serve as Class III directors for a three-year term to expire at the 2027 annual meeting of stockholders: Camille Bedrosian, M.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 2 funds |
| CS DISCO INC. | June 13, 2024 | To elect our three nominees as Class III directors, each to hold office until our Annual Meeting of Stockholders in 2027: Susan L. Blount Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| CUE BIOPHARMA INC. | June 5, 2024 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| CUSTOM TRUCK ONE SOURCE INC. | June 13, 2024 | To amend the Custom Truck One Source, Inc. Amended and Restated 2019 Omnibus Incentive Plan to increase the number of shares available for the grant of awards from 14,650,000 shares to 20,650,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| DESIGN THERAPEUTICS INC. | June 13, 2024 | To elect the one nominee for Class III director named herein to serve for a three-year term until the 2027 Annual Meeting of Stockholders: Pratik Shah, Ph.D. Director Elections |
Board | For | FOR 2 funds |
WITHHOLD 1 fund |
| DRIVEN BRANDS HOLDINGS INC. | May 9, 2024 | Approval of the Amended and Restated Driven Brands Holdings Inc. 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| DULUTH HOLDINGS INC. | May 23, 2024 | To approve the 2024 Equity Incentive Plan of Duluth Holdings Inc. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| EASTMAN KODAK CO. | May 15, 2024 | Approval of the Second Amendment to the Amended and Restated 2013 Omnibus Incentive Plan Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| EGAIN CORP. | December 5, 2023 | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| EHEALTH INC. | June 12, 2024 | Approval, on an advisory basis, of the compensation of the Named Executive Officers of eHealth, Inc. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ENANTA PHARMACEUTICALS INC. | March 6, 2024 | To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ENCORE WIRE CORP. | May 7, 2024 | BOARD PROPOSAL TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| ENTERPRISE BANCORP INC. | May 7, 2024 | Election of the following five directors of the Company, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified, or until their earlier resignation, death or removal from office: Gino J. Baroni Director Elections |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ENTRAVISION COMMUNICATIONS CORP. | May 30, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| ESCALADE INC. | May 8, 2024 | To approve, by non-binding vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| ESSA BANCORP INC. | March 7, 2024 | The consideration of an advisory, non-binding resolution with respect to the executive compensation described in the Proxy Statement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| EXTREME NETWORKS INC. | November 8, 2023 | Approve an amendment and restatement of the Extreme Networks, Inc. 2013 Equity Incentive plan to, among other things, add 5,000,000 shares of our common stock to those reserved for issuance under the plan; and Compensation |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 20, 2024 | To approve an amendment to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to (i) increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares and (ii) increase the individual non-employee director compensation limit contained therein to $850,000 for ongoing directors in any calendar year and $1,100,000 for new directors in any calendar year. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| F&G ANNUITIES & LIFE INC. | July 12, 2023 | Approval of a non-binding advisory resolution on the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 1 fund |
| FARMER BROS. CO. | January 24, 2024 | To hold an advisory (non-binding) vote to approve the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| FATE THERAPEUTICS INC. | June 7, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| FERROGLOBE PLC | June 18, 2024 | THAT, for the purposes of section 694 of the Companies Act, the terms of the buyback contract to be entered into between the Company and any or all of J.P. Morgan Securities LLC, BMO Capital Markets Corp. and Santander US Capital Markets LLC, respectively are approved and the Company be authorized to undertake off-market purchases (within the meaning of section 693(2) of the Companies Act) of its ordinary shares of US $0.01 pursuant to such contracts. Capital Structure |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| FIRST OF LONG ISLAND CORP. | April 16, 2024 | Non-binding, advisory vote to approve the Corporation's executive compensation as discussed in the proxy statement; Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| FIRST WESTERN FINANCIAL INC. | June 5, 2024 | Advisory, non-binding vote to approve the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| FRANKLIN BSP REALTY TRUST INC. | May 29, 2024 | ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| FVCBANKCORP INC. | May 15, 2024 | To Approve the following (non-binding) resolution: Resolved, that the shareholders of FVCBankcorp, Inc., approve the compensation of the named executive of the named executive officers as disclosed in the proxy statement pursuant to the rules of the Securities and Exchange Commission Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| GAMBLING.COM GROUP LTD. | May 15, 2024 | To re-appoint Michael Quartieri as a Class III director of the company. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| GLAUKOS CORP. | May 30, 2024 | Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 7 funds |
| GLOBAL NET LEASE INC. | May 23, 2024 | Approval, on an advisory, non-binding basis, of the compensation paid to the Company's named executive officers identified in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 2 funds |
| GRAPHITE BIO INC. | March 14, 2024 | To approve the 2024 ESPP (as defined in the related proxy statement/prospectus). Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| GRAPHITE BIO INC. | March 14, 2024 | To approve the 2024 Plan (as defined in the related proxy statement/prospectus). Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| GREENLIGHT CAPITAL RE LTD. | July 25, 2023 | To consider and vote upon a proposal to approve and adopt the 2023 Omnibus Incentive Plan; Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| GSI TECHNOLOGY INC. | August 24, 2023 | To vote on an advisory (non-binding) resolution regarding the fiscal 2023 compensation of the executive officers named in the Summary Compensation Table included in the proxy statement for the annual meeting. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| GUARANTY BANCSHARES INC. | May 15, 2024 | Non-binding advisory vote on the compensation of the Company's named executive officers (Say-on-Pay Vote). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| HALLMARK FINANCIAL SERVICES INC. | October 5, 2023 | ADVISORY VOTE ON RESOLUTION TO APPROVE EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| HALLMARK FINANCIAL SERVICES INC. | October 5, 2023 | ELECTION OF DIRECTOR: Mark E. Pape Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| HEIDRICK & STRUGGLES INTERNATIONAL INC. | May 23, 2024 | Approval of the Fifth Amended and Restated Heidrick & Struggles 2012 GlobalShare Program. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| HOVNANIAN ENTERPRISES INC. | March 21, 2024 | Approval of the Third Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| HUDSON PACIFIC PROPERTIES INC. | May 15, 2024 | The advisory approval of the Company's executive compensation for the fiscal year ended December 31, 2023, as more fully disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| IDEAYA BIOSCIENCES INC. | May 31, 2024 | To elect two Class II directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Terry J. Rosen, Ph.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 2 funds |
| INARI MEDICAL INC. | April 24, 2024 | To elect the four nominees for Class I director to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca Chambers Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 5 funds |
| INDIE SEMICONDUCTOR INC. | June 13, 2024 | To approve an amendment to the 2021 Omnibus Equity Incentive Plan to increase the number of shares of Class A Common Stock reserved for issuance thereunder by 7,000,000 shares. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| INTEVAC INC. | May 15, 2024 | Proposal to approve an amendment to the Intevac 2020 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 900,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| INTUITIVE SURGICAL INC. | April 25, 2024 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 15 funds |
FOR 17 funds |
| INVESTAR HOLDING CORP. | May 15, 2024 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| IROBOT CORP. | May 23, 2024 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved and issuable under the 2018 Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| IROBOT CORP. | May 23, 2024 | Approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| JETBLUE AIRWAYS CORP. | May 17, 2024 | To approve an amendment to the JetBlue Airways Corporation 2020 Omnibus Equity Incentive Plan to increase the number of shares of common stock authorized for issuance Compensation |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| KALVISTA PHARMACEUTICALS INC. | September 26, 2023 | The election of two Class II directors to hold office until the earliest of our 2026 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: PATRICK TREANOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| KANZHUN LIMITED | June 28, 2024 | To re-elect Mr. Peng Zhao as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to extend the general mandate granted to the Directors to issue, allot, and deal with additional Shares in the share capital of the Company by the aggregate number of the Shares and| |or Shares underlying the ADSs repurchased by the Company. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to grant a general mandate to the Directors to issue, allot, and deal with additional Class A ordinary shares of the Company not exceeding 20% of the total number of issued Shares (excluding treasury shares) of the Company as of the date of passing of this resolution. Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Jun Wu as an independent nonexecutive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Yigang Shan as an executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 2 funds |
Page 1 of 5 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.